Soumya P. Sahoo - Concepedia

Author

Soumya P. Sahoo

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

S. P. SAHOO, S. SAHOO, Soumya P Sahoo, Soumya P. Sahoo, Soumya Sahoo, Soumya Swastik Sahoo

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Université de Montréal United States Military Academy Institute for Atherosclerosis Research

About

Soumya P. Sahoo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	485
2	Biochemistry	12	15	495
3	Natural Sciences	10	11	353
4	Engineering	6	6	174
5	Health Sciences	1	1	42

Soumya P. Sahoo

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects Joel P. Berger, Mark D. Leibowitz, Thomas W. Doebber, Journal of Biological Chemistry	1999	411
Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump Jisong Cui, Li Huang, Annie Zhao, Journal of Biological Chemistry	2003	239
Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids: Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity Guo Q. Shi, James F. Dropinski, Yong Zhang, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistryMedicine	2005	98
Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation S.M. Soisson, Gopalakrishnan Parthasarathy, Alan D. Adams, Proceedings of the National Academy of Sciences	2008	90
A Novel Liver X Receptor Agonist Establishes Species Differences in the Regulation of Cholesterol 7α-Hydroxylase (CYP7a) John G. Menke, Karen L. MacNaul, Nancy S. Hayes, Endocrinology	2002	76
A novel and efficient synthesis of L-vinylglycine Stephen Hanessian, Soumya P. Sahoo Tetrahedron Letters EngineeringOrganic ChemistryEfficient SynthesisStereoselective SynthesisNatural Product Synthesis	1984	71
5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents Ranjit C. Desai, Wei Han, E. Joseph Metzger, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ScienceBiochemistryMedicineMechanism Of Action5-Aryl Thiazolidine-2,4-diones	2003	57
(2<i>R</i>)-2-Ethylchromane-2-carboxylic Acids: Discovery of Novel PPARα/γ Dual Agonists as Antihyperglycemic and Hypolipidemic Agents Hiroo Koyama, Daniel J. Miller, Julia K. Boueres, Journal of Medicinal Chemistry Ppar Agonist ActivitiesMetabolic SyndromeLipid SynthesisBiochemistryDog Lipid Model	2004	55
Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice John G. DeLuca, Thomas W. Doebber, Linda J Kelly, Molecular Pharmacology	2000	53
A tactically novel alternative to acyclic stereoselection based on the concept of a replicating chiron — 1,3- and 1,4-C-Methyl substitution Stephen Hanessian, Peter J. Murray, Soumya P. Sahoo Tetrahedron Letters 1,4-C-methyl SubstitutionOrganic ChemistryStereoselective SynthesisChemistryAsymmetric Catalysis	1985	51

Page 1